Literature DB >> 31000193

Population versus individual protection by pneumococcal conjugate vaccination.

Keith P Klugman1, Gail L Rodgers2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31000193      PMCID： PMC7771528          DOI： 10.1016/S0140-6736(19)30039-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.

Authors:  Betuel Sigaúque; Benild Moiane; Sergio Massora; Fabiana Pimenta; Jennifer R Verani; Helio Mucavele; Alberto Chaúque; Llorenç Quintó; Rita T Dos Santos; Maria da Gloria Carvalho; Cynthia G Whitney; Fernanda C Lessa
Journal:  Pediatr Infect Dis J       Date:  2018-10       Impact factor: 2.129

2.  Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.

Authors:  Susan A Nzenze; Shabir A Madhi; Tinevimbo Shiri; Keith P Klugman; Linda de Gouveia; David P Moore; Alan S Karstaedt; Stefano Tempia; Marta C Nunes; Anne von Gottberg
Journal:  Am J Epidemiol       Date:  2017-08-15       Impact factor: 4.897

3.  Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children.

Authors:  Anita M Loughlin; Katherine Hsu; Amy L Silverio; Colin D Marchant; Stephen I Pelton
Journal:  Pediatr Infect Dis J       Date:  2014-05       Impact factor: 2.129

4.  Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

Authors:  Matthew R Moore; Ruth Link-Gelles; William Schaffner; Ruth Lynfield; Catherine Lexau; Nancy M Bennett; Susan Petit; Shelley M Zansky; Lee H Harrison; Arthur Reingold; Lisa Miller; Karen Scherzinger; Ann Thomas; Monica M Farley; Elizabeth R Zell; Thomas H Taylor; Tracy Pondo; Loren Rodgers; Lesley McGee; Bernard Beall; James H Jorgensen; Cynthia G Whitney
Journal:  Lancet Infect Dis       Date:  2015-02-03       Impact factor: 25.071

5.  Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial.

Authors:  David Goldblatt; Jo Southern; Nick J Andrews; Polly Burbidge; Jo Partington; Lucy Roalfe; Marta Valente Pinto; Vasilli Thalasselis; Emma Plested; Hayley Richardson; Matthew D Snape; Elizabeth Miller
Journal:  Lancet Infect Dis       Date:  2017-11-22       Impact factor: 25.071

6.  Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.

Authors:  Jo Southern; Nick Andrews; Pamela Sandu; Carmen L Sheppard; Pauline A Waight; Norman K Fry; Albert Jan Van Hoek; Elizabeth Miller
Journal:  PLoS One       Date:  2018-05-25       Impact factor: 3.240

7.  Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.

Authors:  Laura L Hammitt; Anthony O Etyang; Susan C Morpeth; John Ojal; Alex Mutuku; Neema Mturi; Jennifer C Moisi; Ifedayo M Adetifa; Angela Karani; Donald O Akech; Mark Otiende; Tahreni Bwanaali; Jackline Wafula; Christine Mataza; Edward Mumbo; Collins Tabu; Maria Deloria Knoll; Evasius Bauni; Kevin Marsh; Thomas N Williams; Tatu Kamau; Shahnaaz K Sharif; Orin S Levine; J Anthony G Scott
Journal:  Lancet       Date:  2019-04-15       Impact factor: 79.321

8.  Association Between the Decline in Pneumococcal Disease in Unimmunized Adults and Vaccine-Derived Protection Against Colonization in Toddlers and Preschool-Aged Children.

Authors:  Daniel M Weinberger; Virginia E Pitzer; Gili Regev-Yochay; Noga Givon-Lavi; Ron Dagan
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

9.  Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.

Authors:  Ellen Heinsbroek; Terence Tafatatha; Amos Phiri; Todd D Swarthout; Maaike Alaerts; Amelia C Crampin; Christina Chisambo; Oddie Mwiba; Jonathan M Read; Neil French
Journal:  Vaccine       Date:  2018-10-21       Impact factor: 3.641

10.  Persistence of Nasopharyngeal Pneumococcal Vaccine Serotypes and Increase of Nonvaccine Serotypes Among Vaccinated Infants and Their Mothers 5 Years After Introduction of Pneumococcal Conjugate Vaccine 13 in The Gambia.

Authors:  Effua Usuf; Christian Bottomley; Ebrima Bojang; Isatou Cox; Abdoulie Bojang; Rebecca Gladstone; Beate Kampmann; Philip C Hill; Anna Roca
Journal:  Clin Infect Dis       Date:  2019-04-24       Impact factor: 9.079
View more
  3 in total

1.  Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials.

Authors:  Kaatje Bollaerts; Mark A Fletcher; Jose A Suaya; Germaine Hanquet; Marc Baay; Bradford D Gessner
Journal:  Clin Infect Dis       Date:  2022-04-28       Impact factor: 20.999

2.  Estimating the contribution of HIV-infected adults to household pneumococcal transmission in South Africa, 2016-2018: A hidden Markov modelling study.

Authors:  Deus Thindwa; Nicole Wolter; Amy Pinsent; Maimuna Carrim; John Ojal; Stefano Tempia; Jocelyn Moyes; Meredith McMorrow; Jackie Kleynhans; Anne von Gottberg; Neil French; Cheryl Cohen; Stefan Flasche
Journal:  PLoS Comput Biol       Date:  2021-12-23       Impact factor: 4.475

3.  Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.

Authors:  Heidi M Soeters; Dinanibè Kambiré; Guetawendé Sawadogo; Rasmata Ouédraogo-Traoré; Brice Bicaba; Isaïe Medah; Lassana Sangaré; Abdoul-Salam Ouédraogo; Soumeya Ouangraoua; Issaka Yaméogo; Malika Congo-Ouédraogo; Absatou Ky Ba; Flavien Aké; Velusamy Srinivasan; Ryan T Novak; Lesley McGee; Cynthia G Whitney; Chris Van Beneden
Journal:  J Infect Dis       Date:  2019-10-31       Impact factor: 5.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.